| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 58905-32-1 | 3,3-二甲基-1-(1H-1,2,4-三唑-1-基)丁-2-酮 | 3,3-Dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-one; 1,2,4-Triazol-1-ylpinacolin; 3,3-Dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one; 3,3-Dimethyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone |  | C8H13N3O | 詳情 | 供應(yīng)商 |
| 96518-36-4 | Apamin,N-[N-(4-azido-2-nitrophenyl)glycyl]-18-[(iodo-125I)-L-histidinamide]- (9CI); 32,15-(Iminoethaniminopropanodithiomethano)-31H-pyrrolo[2,1-e1][1,2,5,8,11,14,17,20,23,26,29,32,35,38]dithiadodecaazacyclohentetracontine,cyclic peptide deriv. |  | C87H135IN36O27S4 | 詳情 | 供應(yīng)商 | |
| 956107-26-9 | Acetamide,N-[2-(1H-imidazol-5-yl)-1-methylethyl]-; Acetamide, N-[2-(1H-imidazol-5-yl)-1-methylethyl]- |  | C8H13N3O | 詳情 | 供應(yīng)商 | |
| 18923-39-2 | Cytidine-2-14C,2'-deoxy- (7CI,8CI,9CI); Deoxycytidine-2-14C |  | C8(14C)H13N3O4 | 詳情 | 供應(yīng)商 | |
| 763887-37-2 | Ethanone,1-[2-[(dimethylamino)methyl]-1H-imidazol-5-yl]-; Ethanone,1-[2-[(dimethylamino)methyl]-1H-imidazol-4-yl]- (9CI) |  | C8H13N3O | 詳情 | 供應(yīng)商 | |
| 98013-37-7 | Ethanone,1-[1-(1,1-dimethylethyl)-1H-1,2,3-triazol-4-yl]-; 1H-1,2,3-Triazole,ethanone deriv. |  | C8H13N3O | 詳情 | 供應(yīng)商 | |
| 750643-40-4 | Formamide,N-[4-methyl-2-(1-methylethyl)-1H-imidazol-5-yl]-; Formamide,N-[5-methyl-2-(1-methylethyl)-1H-imidazol-4-yl]- (9CI) |  | C8H13N3O | 詳情 | 供應(yīng)商 | |
| 46056-39-7 | Hydrazinecarboxamide,2-(bicyclo[3.2.0]hept-6-ylidene)-; Hydrazinecarboxamide,2-bicyclo[3.2.0]hept-6-ylidene- (9CI); Bicyclo[3.2.0]heptane, hydrazinecarboxamide deriv.; NSC 119486 |  | C8H13N3O | 詳情 | 供應(yīng)商 | |
| 56967-87-4 | Hydrazinecarboxamide,2-(3-methyl-2-cyclohexen-1-ylidene)-; 2-Cyclohexen-1-one,3-methyl-, semicarbazone (6CI,7CI); D2-Cyclohexenone, 3-methyl-, semicarbazone (1CI); NSC408774 |  | C8H13N3O | 詳情 | 供應(yīng)商 | |
| 54534-92-8 | Morpholine,4-(1H-imidazol-2-ylmethyl)-; 2-(Morpholinomethyl)imidazole; NSC 116534 |  | C8H13N3O | 詳情 | 供應(yīng)商 | |
| 157214-61-4 | Protegrin 4 (9CI); L-Argininamide,L-arginylglycylglycyl-L-arginyl-L-leucyl-L-cysteinyl-L-tyrosyl-L-cysteinyl-L-arginylglycyl-L-tryptophyl-L-isoleucyl-L-cysteinyl-L-valyl-L-cysteinyl-L-valylglycyl-,cyclic (6® 15),(8® 13)-bis(disulfide); Protegrin 4 (swine precursor); Protegrin PG 4 (pig reduced); Protegrin PG 4 (swine reduced); Protegrin PG-4(pig strain Duroc bone marrow cell) |  | C86H138N32O19S4 | 詳情 | 供應(yīng)商 | |
| 161609-79-6 | Piperidine,4-(5-methyl-1,3,4-oxadiazol-2-yl)- |  | C8H13N3O | 詳情 | 供應(yīng)商 | |
| 40778-16-3 | R 31805; 2-(dimethylamino)-5,6-dimethyl-1H-pyrimidin-4-one; ddhp; 4,5-DIMETHYL-2-(DIMETHYLAMINO)-6-HYDROXYPYRIMIDINE; 2-(dimethylamino)-5,6-dimethylpyrimidin-4-ol; 2-dimethylamino-4-hydroxy-5，6-dimetyhl pyrimidine |  | C8H13N3O | 詳情 | 供應(yīng)商 | |
| 113630-76-5 | 1H-Pyrazole-1-carboxamide,3-methyl-5-(1-methylethyl)-; 1H-Pyrazole-1-carboxamide,3-methyl-5-(1-methylethyl)-(9CI) |  | C8H13N3O | 詳情 | 供應(yīng)商 | |
| 5230-07-9 | 1H-Pyrazole-1-carboxamide,N,N,3,4-tetramethyl-; Pyrazole-1-carboxamide,N,N,3,4-tetramethyl- (7CI,8CI) |  | C8H13N3O | 詳情 | 供應(yīng)商 | |
| 713071-47-7 | 1H-Imidazole-5-propanamide,N,N-dimethyl-; 1H-Imidazole-4-propanamide,N,N-dimethyl- (9CI) |  | C8H13N3O | 詳情 | 供應(yīng)商 | |
| 743373-08-2 | 1,3-Diazabicyclo[3.3.1]non-2-en-6-one,2-amino-4-methyl-; 1,3-Diazabicyclo[3.3.1]non-2-en-6-one,2-amino-4-methyl-(9CI) |  | C8H13N3O | 詳情 | 供應(yīng)商 | |
| 236098-40-1 | PHE-GLY-GLY-PHE-THR-GLY-ALA-ARG-LYS-SER-ALA-ARG-LYS-ARG-LYS-ASN-GLN; [ARG14,LYS15]NOCICEPTIN; [ARG14, LYS15]NOCICEPTIN/ORPHANIN FQ; [ARG14,LYS15] ORPHANIN FQ; PHE-GLY-GLY-PHE-THR-GLY-ALA-ARG-LYS-SER-ALA-ARG-LYS-ARG-LYS-ASN-GLN |  | C82H137N31O22 | 詳情 | 供應(yīng)商 | |
| 1219332-91-8 | rac Lenalidomide-13C5; 1-Oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline-13C5; 3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione-13C5; CC-5013-13C5; rac Lenalidomide-13C5; Revimid-13C5; Revlimid-13C; Revlimid-13C5 | 無(wú) | C8(13C)5H13N3O3 | 詳情 | 供應(yīng)商 | |
| 230953-34-1 | POLY(4-(2 2-DICYANOVINYL)-N-BIS(HYDROXY& | 無(wú) | [(C14H13N3O2)(C8H4O2)]n | 詳情 | 供應(yīng)商 | |